Mycenax Biotech Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 69.861 million compared to TWD 66.382 million a year ago. Operating loss was TWD 25.923 million compared to TWD 59.257 million a year ago. Net loss was TWD 21.603 million compared to TWD 52.160 million a year ago. Basic loss per share was TWD 0.17 compared to TWD 0.44 a year ago.